Young-Onset Pancreatic Cancer Rise: Overdiagnosis Link to Early-Stage Endocrine Cancer Explained

Young-Onset Pancreatic Cancer Rise: Overdiagnosis Link to Early-Stage Endocrine Cancer Explained

November 18, 2024 Catherine Williams - Chief Editor Health

A recent study has found that pancreatic cancer cases in young adults (ages 15-39) are increasing, but the death rate has remained stable. Researchers led by Patel reported in the Annals of Internal Medicine that the rise in cases is mainly due to better detection of small, early-stage endocrine cancers, not pancreatic adenocarcinoma. This suggests that more cases are being detected rather than an actual rise in cancer occurrences.

Study Methodology

The team collected data on pancreatic cancer from 2001 to 2019 through the U.S. Cancer Statistics and the National Vital Statistics System. They categorized cancer types using the International Classification of Diseases for Oncology.

Key Results

The study found a 2.1-fold increase in pancreatic cancer incidence among young women (from 3.3 to 6.9 per million) and a 1.6-fold increase among young men (from 3.9 to 6.2 per million). The rate of surgeries for pancreatic cancer significantly rose, doubling in both women and men, yet the death rate remained stable (about 1.5 deaths per million for women and 2.5 for men).

Most new cases discovered were early-stage cancers. Incidence rates of small tumors increased significantly, with early-stage cancer in women rising from 0.6 to 3.7 per million and in men from 0.4 to 2.2 per million. There were no significant changes in late-stage cancer rates.

The increase was not seen in adenocarcinoma cases. The study indicated that the rise primarily involved endocrine cancer and solid pseudopapillary neoplasms. For women, the incidence of endocrine cancer rose from 0.9 to 2.8 per million, while for men it increased from 0.6 to 2.8 per million.

Conclusion

The authors concluded that the rising incidence of pancreatic cancer in young people is primarily due to detecting smaller, early-stage endocrine cancers. The stable mortality rates point to better detection rather than a true increase in cancer cases.

For more details, visit the Annals of Internal Medicine.